Max Resource Discovers New Copper-Silver Zone at the AM District CESAR Project

Investing News NetworkYour trusted source for investing success

Download our investor reports
Start Here GuidesOutlook Reports
Copyright 2023 © Dig Media Inc.

Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.

cynata therapeutics

LATEST ARTICLES
Genetics Outlook 2019: CRISPR Technology Advances
Genetics Investing

Genetics Outlook 2019: CRISPR Technology Advances

Genetics Investing

Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology

Genetics Investing
Genetics Investing

Cynata Therapeutics Receives Orphan Drug Designation from FDA

Genetics Investing

FDA Grants Orphan Drug Designation to Cynata’s Lead Cymerus MSC Product, CYP-001

Genetics Investing

Excellent Cohort A Data From Final Primary Evaluation Period in Cynata GvHD Phase 1 Clinical Trial

Biotech Investing

Treatment Commences in Second Patient Cohort in Cynata’s World First Clinical Trial

Longevity Investing

Cynata Executes MoU for Commercial Evaluation with Celularity

Biotech Investing
Biotech Investing

What Is Regenerative Medicine?

Genetics Investing
Genetics Investing

Genetics Outlook 2017: The Revolution Nears

Biotech Investing
Biotech Investing

Top Trends for Genetics Stocks in 2017

MARKETS

Markets
TSX19920.31+146.23
TSXV604.09+1.45
DOW33093.34+328.69
S&P 5004205.45+54.17
NASD12975.69+277.59
ASX7154.80+16.60

COMMODITIES

Commodities
Gold1948.77+4.73
Silver23.22-0.07
Copper3.68+0.09
Palladium1713.170.00
Platinum1087.260.00
Oil72.14+0.31
Heating Oil2.340.00
Natural Gas2.36+0.05

DOWNLOAD FREE REPORTS

BROWSE COMPANIES BY SECTOR

loader